No recent analyst price targets found for PPTDF.
Latest News for PPTDF
PeptiDream Inc. (PPTDF) Q4 2025 Earnings Call Transcript
PeptiDream Inc. (PPTDF) Q4 2025 Earnings Call Transcript
Curium Group, PeptiDream and PDRadiopharma Enroll First Patient to Registrational Clinical Trial of Lu-PSMA-I&T for Prostate Cancer in Japan
BOSTON, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Curium Group today announced that together with PeptiDream Inc. and PDRadiopharma Inc., the first patient has been dosed in the companies' registrational clinical trial of 177Lu-PSMA-I&T in Japan for patients with PSMA (*1)-positive metastatic castration-resistant prostate cancer (mCRPC).
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for PPTDF.
Senate Trading
No Senate trades found for PPTDF.
U.S. House Trading
No House trades found for PPTDF.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.